Our team will participate in fireside chats during two upcoming investor conferences in July including the H.C. Wainwright 4th Annual Kidney Virtual Conference and the BTIG Virtual Biotech Conference. Live webcasts of the events will be available in the Investors section of our

Tomorrow is International PKU Day, and we stand with the global community raising awareness of #phenylketonuria (PKU), a rare, inherited metabolic disorder, and the ongoing need for innovative treatments. At Maze, we are driven by our mission to translate genetic insights into

Today, Maze honors #Juneteenth, a pivotal moment in U.S. history that commemorates the end of slavery and calls us to reflect on the ongoing pursuit of equity and justice. Our offices are closed in recognition of this day — a time to pause, learn, and consider how we, as

Mazers recently stepped up for the @NKF Northern California Kidney Walk and made it count. We’re proud to have surpassed our fundraising goal, setting a new company record and earning a spot among the event’s top fundraisers. A heartfelt thank you to everyone who donated, walked,

To celebrate Asian American, Native Hawaiian, and Pacific Islander Heritage Month, Mazers gathered for a special game night that honored the rich traditions of #AANHPI communities. We focused on the theme of resilience and rebuilding and how cherished cultural traditions like

Our CEO Jason Coloma, Ph.D., will present a company overview at the 2025 #JefferiesHealthcare Conference on Thursday, June 5, 2025, at 2 p.m. ET. A live webcast will be available in the Investors section of our website and archived for 60 days following the presentation.

During #PKUAwareness Month and every month, we stand with the PKU community. Phenylketonuria (PKU) is a rare genetic disorder that requires lifelong management. At Maze, we’re advancing research with the goal of easing that burden. Our investigational therapy, MZE782, is an oral

On #ClinicalTrialsDay, we recognize those who make clinical progress possible. Our science starts with genetics, but it’s driven by something deeply human: a strong commitment to improving lives. Our HORIZON trial reflects this mission and is the first study of a #small molecule

Today we reported financial results for the first quarter ended March 31, 2025, and reiterated upcoming milestones. Read the full announcement here:

Our CEO Jason Coloma, Ph.D., will present a company overview at the 3rd Annual H.C. Wainwright BioConnect Investor Conference next Tuesday at 11 a.m. ET. A live webcast will be available in the Investors section of our website and archived for 60 days following the presentation.

We are pleased to introduce you to Maze's patient advisory committee (PAC), comprised of representatives and allies of the APOL1 #kidneydisease and chronic kidney disease (CKD) patient communities. This committee ensures that the voices of patients and caregivers are at the

At Maze, we believe that even small actions can make a big impact when it comes to protecting our planet. To celebrate #EarthDay, our team came together last week for a day of sustainable activities including a clothing, toy, and household item swap, a plant swap, and delicious

In honor of APOL1 Awareness Day, we're proud to share a new resource for the APOL1 #kidneydisease community. This resource provides accessible, expert-informed information for individuals and families affected by APOL1 kidney disease, especially those of African ancestry, who are

This #DNADay, we’re celebrating the power of genetics to unlock new possibilities in medicine and the people pushing science forward. We were honored to host Dr. Doug Fowler, professor of Genome Sciences and Bioengineering at the @UW, for a seminar on measuring human genetic

APOL1 kidney disease refers to chronic #kidneydisease in patients with APOL1 gene variants. All individuals inherit two copies of the APOL1 gene. However, certain changes in this gene can raise the risk of chronic kidney disease—particularly in people of African ancestry. At

On behalf of Maze, our Director of Patient Advocacy and Community Outreach Danielle Branch participated in @ALKidneyFound’s (AKF) #HuntsvilleKidneyWalk. Maze was a proud sponsor of the event which supported local #kidneydisease patients in need and helped to fund treatment

Today we announced fourth quarter and year-end 2024 financial results and highlighted recent progress and upcoming milestones. Learn more about the meaningful progress we are making with our two clinical-stage programs — MZE829 in APOL1 #kidneydisease and MZE782 in chronic kidney

In honor of #WomensHistoryMonth, we hosted a company panel focused on the experiences of women in science, the most meaningful lessons learned and strategies for overcoming challenges. This year's theme “Moving Forward Together! Women Educating & Inspiring Generations" embodies

This #InternationalWomensDay, we’re celebrating women who inspire one another and #AccelerateAction by advancing science and shaping culture. Some members of the Maze team have shared what it means to them to lead with purpose and create lasting impact in the work we do every

On #RareDiseaseDay, we recognize and draw attention to the challenges faced by those living with a rare diseases, and we stand with the #raredisease community in bringing awareness and seeking solutions to often overlooked or underserved conditions. At Maze, we are committed to